Luperacus Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Luperacus General Information

Description

Operator of a biotechnology company based in the United Kingdom. The company has developed novel therapeutic antibodies to treat canine and human cancer, enabling medical professional to treat cancer in humans and dogs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6 Riverside Court, Mayo Avenue
  • Angus
  • Dundee DD2 1XD
  • Scotland, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 6 Riverside Court, Mayo Avenue
  • Angus
  • Dundee DD2 1XD
  • Scotland, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Luperacus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jan-2021 Completed Startup
1. Early Stage VC Completed Startup
To view Luperacus’s complete valuation and funding history, request access »

Luperacus Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innova Partnerships Venture Capital Minority
To view Luperacus’s complete investors history, request access »

Luperacus FAQs

  • When was Luperacus founded?

    Luperacus was founded in 2016.

  • Where is Luperacus headquartered?

    Luperacus is headquartered in Dundee, United Kingdom.

  • What industry is Luperacus in?

    Luperacus’s primary industry is Drug Discovery.

  • Is Luperacus a private or public company?

    Luperacus is a Private company.

  • What is Luperacus’s current revenue?

    The current revenue for Luperacus is .

  • Who are Luperacus’s investors?

    Innova Partnerships has invested in Luperacus.

  • When was Luperacus acquired?

    Luperacus was acquired on 01-Jan-2021.

  • Who acquired Luperacus?

    Luperacus was acquired by ABBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process